Tibet Weixinkang Medicine Co Ltd (603676) - Total Liabilities

Latest as of March 2026: CN¥406.29 Million CNY ≈ $59.45 Million USD

Based on the latest financial reports, Tibet Weixinkang Medicine Co Ltd (603676) has total liabilities worth CN¥406.29 Million CNY (≈ $59.45 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Tibet Weixinkang Medicine Co Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Tibet Weixinkang Medicine Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Tibet Weixinkang Medicine Co Ltd (603676) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Tibet Weixinkang Medicine Co Ltd Competitors by Total Liabilities

The table below lists competitors of Tibet Weixinkang Medicine Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
LUBAWA SA WAR:LBW	Poland	zł151.17 Million
Guangxi Nanning Waterworks Co SHG:601368	China	CN¥21.35 Billion
Shanghai GuAo Electronic Technology Co Ltd SHE:300551	China	CN¥115.69 Million
Liberty Gold Corp TO:LGD	Canada	CA$6.55 Million
Dexus Industria REIT AU:DXI	Australia	AU$337.68 Million
Gulf Oil Lubricants India Limited NSE:GULFOILLUB	India	Rs11.99 Billion
NRJ Group PA:NRG	France	€176.79 Million
Clearfield Inc NASDAQ:CLFD	USA	$20.74 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Tibet Weixinkang Medicine Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Tibet Weixinkang Medicine Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tibet Weixinkang Medicine Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tibet Weixinkang Medicine Co Ltd (2013–2025)

The table below shows the annual total liabilities of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥390.49 Million ≈ $57.14 Million	-16.61%
2024-12-31	CN¥468.24 Million ≈ $68.52 Million	+7.26%
2023-12-31	CN¥436.55 Million ≈ $63.88 Million	-1.71%
2022-12-31	CN¥444.13 Million ≈ $64.99 Million	+3.70%
2021-12-31	CN¥428.31 Million ≈ $62.67 Million	+13.65%
2020-12-31	CN¥376.85 Million ≈ $55.15 Million	+0.61%
2019-12-31	CN¥374.56 Million ≈ $54.81 Million	+11.04%
2018-12-31	CN¥337.33 Million ≈ $49.36 Million	+112.71%
2017-12-31	CN¥158.58 Million ≈ $23.21 Million	+70.64%
2016-12-31	CN¥92.94 Million ≈ $13.60 Million	-12.18%
2015-12-31	CN¥105.82 Million ≈ $15.49 Million	+37.27%
2014-12-31	CN¥77.09 Million ≈ $11.28 Million	+25.31%
2013-12-31	CN¥61.52 Million ≈ $9.00 Million	--

About Tibet Weixinkang Medicine Co Ltd

SHG:603676 China Drug Manufacturers - Specialty & Generic

Market Cap

$550.18 Million

CN¥3.76 Billion CNY

Market Cap Rank

#11878 Global

#3439 in China

Share Price

CN¥8.64

Change (1 day)

+0.47%

52-Week Range

CN¥8.60 - CN¥14.17

All Time High

CN¥24.05